Henry Joyce Cancer Center — Nashville, Tennessee

Henry Joyce Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Henry Joyce Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Multiple Myeloma, Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial.

Sponsors: Pfizer, Amgen.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Joyce Cancer Center?

Henry Joyce Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Joyce Cancer Center conducted?

Henry Joyce Cancer Center has 2 clinical trials on record. Their work covers Multiple Myeloma, Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial.

Is Henry Joyce Cancer Center accredited by Crixeo Health?

Henry Joyce Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Henry Joyce Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.